Dexcom Beats Abbott's Glucose Monitor Infringement Claims

Abbott Laboratories has failed to persuade a London court that its rival Dexcom's blood-sugar monitoring device infringed its intellectual property, because its patent claims described a slightly different way to insert...

Already a subscriber? Click here to view full article